Try our new research platform with insights from 80,000+ expert users
IBM B2B Integrator Logo

IBM B2B Integrator Reviews

Vendor: IBM
3.9 out of 5
889 followers
Post review

What is IBM B2B Integrator?

Featured reviews

IBM B2B Integrator mindshare

As of December 2024, the mindshare of IBM B2B Integrator in the Business-to-Business Middleware category stands at 7.3%, down from 7.4% compared to the previous year, according to calculations based on PeerSpot user engagement data.
Business-to-Business Middleware

PeerAnalyst reports

TypeTitleDate
CategoryBusiness-to-Business MiddlewareDec 21, 2024Download
ProductReviews, tips, and advice from real usersDec 21, 2024Download
ComparisonIBM B2B Integrator vs SAP Process OrchestrationDec 21, 2024Download
ComparisonIBM B2B Integrator vs MuleSoft Anypoint PlatformDec 21, 2024Download
ComparisonIBM B2B Integrator vs Informatica Intelligent Data Management Cloud (IDMC)Dec 21, 2024Download
Suggested products
TitleRatingMindshareRecommending
Informatica Intelligent Data Management Cloud (IDMC)4.0N/A93%181 interviewsAdd to research
MuleSoft Anypoint Platform4.014.0%91%56 interviewsAdd to research
 
 
Key learnings from peers

Valuable Features

Valuable Features

Room for Improvement

Room for Improvement

ROI

Pricing

Pricing

Popular Use Cases

Service and Support

Deployment

Scalability

Stability

Review data by company size

By reviewers
By visitors reading reviews

Top industries

By visitors reading reviews
Computer Software Company
16%
Manufacturing Company
14%
Financial Services Firm
11%
Healthcare Company
7%
Retailer
7%
Logistics Company
6%
Wholesaler/Distributor
4%
Insurance Company
4%
Real Estate/Law Firm
3%
Media Company
3%
Energy/Utilities Company
3%
University
3%
Educational Organization
3%
Transportation Company
3%
Construction Company
2%
Government
2%
Legal Firm
2%
Recreational Facilities/Services Company
1%
Comms Service Provider
1%
Consumer Goods Company
1%
Hospitality Company
1%
Agriculture
1%
Leisure / Travel Company
1%
Outsourcing Company
1%
Non Profit
1%
Pharma/Biotech Company
1%